For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts

Blog
States can keep Medicaid whole if they want
Congress is considering slowing Medicaid growth over the next 10 years enough to reduce federal spending by $625 billion. Many Republicans argue that the…
The Washington Examiner
Capping drug prices will cripple innovation and harm public health
The Washington Examiner cited CEI’s expert on life-saving drugs and technology The Competitive Enterprise Institute was similarly scathing. “As with many industries, the United States…
The Epoch Times
What to Know About Trump’s Plan to Slash Drug Prices
The Epoch Times cited CEI’s expert on drug prices “Jeremy Nighohossian, a senior fellow at the Competitive Enterprise Institute, a libertarian think tank, told The…
Search Posts
Study
A Free Market Solution for Drug Distribution
Executive summary This paper describes and explains the function of Pharmacy Benefit Managers (PBMs) in the American health care economy. PBMs are private businesses that…
New York Post
Djokovic can compete in the US Open again — after Biden finally ended his unscientific travel ban
The US Open tennis tournament has begun in Queens, and one of the world’s best players will finally be allowed to compete again. Novak…
New York Post
Don’t believe doomsayers — new COVID outbreak is mild, and masks don’t help
COVID-19 cases are expected to rise this fall as new variants become more prevalent. And, as unfortunately expected, it’s already triggered demands by…
Fox News
New report reveals how CDC can be ready for the next pandemic
The Centers for Disease Control and Prevention has a new director, Dr. Mandy Cohen. Her predecessor, Dr. Rochelle Walensky, acknowledged CDC was…
Citation
Dr. Joel Zinberg discusses his report on refocusing and reforming the CDC after COVID-19 on C-SPAN’s Washington Journal
CEI Senior Fellow Joel Zinberg joined Washington Journal on August 11, 2023 to discuss new study from CEI and Paragon Health Institute which found…
News Release
New Study from CEI and Paragon Health Institute finds CDC shortcomings and recommends key reforms
The Competitive Enterprise Institute (CEI) and the Paragon Health Institute published a new paper today by CEI senior fellow and director of…